Comparison of the Different Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Mice in the Enteric Nervous System
Abstract
Abstract Background As “the second brain”, the gastrointestinal tract contains an intrinsic neuronal network: the Enteric Nervous System (ENS). The ENS governs motility, fluid homeostasis, and blood flow, and it also works with other parts of the intestine, playing a vital role in the occurrence and development of IBS-D. Methods To assess the effects of different IBS-D rat models (life stress, chemical enema stimulation, and compound stimulation ) on the ENS, we have established three models of BALB/c mice by wrapping restrain stress (WRS), a single administration of trinitro-benzene-sulfonic acid with 50ul (TNBS, 2mg/mouse in 50% ethanol), and WRS + TNBS. We have also determined Cytokine levels, the activity of intestinal neurons, intestinal mucosal barrier function, intestinal neurotransmitters, and structural changes of intestinal nerve cells after inducing IBS-D. Results This research found that the intervention of TNBS + WRS, WRS, and TNBS would induce a similar course of effects on the ENS. Among the three models, the distance at the open-field test decreased with speed, AWR scores (at 0.6ml), and intestinal permeability all increased. The levels of 5- hydroxytryptamine in colon tissue rapidly increased, whereas serum showed no significant changes. Using TEM to observe monocyte cells infiltrating neuronal cells and the structural changes in neurons. According to Western blot, HTR3A, C-fos level increased, and PGP9.5 decreased in TNBS + WRS and WRS modeling groups.…
How strong is the evidence?
Evidence Hub reads this as a preprint, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.